INVA FY 2017 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$217M+62.6% YoY

Gross Profit

$216M99.4% margin

Operating Income

$184M84.5% margin

Net Income

$134M61.8% margin

EPS (Diluted)

$1.17

Cash Flow

Operating Cash Flow

$142M

Free Cash Flow

$142M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$367M

Total Liabilities

$610M

Stockholders' Equity

-$243M

Cash & Equivalents

$73M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$217M	$134M	+62.6%
Gross Profit	$216M	$132M	+63.3%
Operating Income	$184M	$109M	+68.5%
Net Income	$134M	$60M	+125.3%